Clinical Trial Update: Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study [Phase 3]

View source ↗

Summary

Pilot prospective cohort study investigating the effects of antiplatelet and antioxidant agents on drusen progression in dry age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration

Drugs mentioned

• Antioxidant agents
• Antiplatelet agents

Snippet

Sponsor: Navamindradhiraj University | Conditions: Dry Age-related Macular Degeneration | Phase 3 | Status: RECRUITING